Journal of Applied Physiology, Vol 72, Issue 4 1320-1325, Copyright © 1992 by American Physiological Society

ARTICLES

Prophylactic effects of dexamethasone in lung injury caused by hyperoxia and hyperventilation

J. M. Davis and J. Whitin
Department of Pediatrics, Neonatology, Hematology-Oncology, University of Rochester School of Medicine and Dentistry, New York 14642.

To determine if prophylactic corticosteroids would prevent acute lung injury caused by hyperoxia and barotrauma, 29 piglets (1.2 +/- 0.3 kg, 1-2 days of age) were studied. Ten piglets were hyperventilated [arterial PCO2 (PaCO2) 15-20 Torr] with 100% O2 for 48 h and compared with 10 piglets treated with the identical management but given 0.7 mg/kg of dexamethasone at time 0 and every 12 h for the 48-h study. Six piglets were normally ventilated (PaCO2 40-45 Torr) for 48 h with 21% O2 as an additional control group. Pulmonary function and tracheal aspirates were examined at time 0 and every 24 h. Bronchoalveolar lavage was performed for surfactant analyses at the conclusion of the study. In animals treated with hyperoxia and hyperventilation, lung compliance decreased 32% and tracheal aspirate polymorphonuclear leukocyte (PMN) chemotactic activity increased by 51%, cell counts by 204%, number of PMNs by 277%, elastase activity by 111%, and albumin concentration by 328% over 48 h (P less than 0.05). In contrast, dexamethasone-treated piglets had increases in only tracheal aspirate albumin concentration (206%) over the 48-h study. All cellular and biochemical variables were lower in dexamethasone-treated compared with hyperoxic hyperventilated piglets. Room air normal ventilation controls had only a 108% increase in tracheal aspirate albumin concentration noted. Despite quantitative differences in surfactant among the three groups, activity was unaffected. Results indicate that hyperoxia and hyperventilation for 48 h causes significant inflammatory changes and acute lung injury and that prophylactic high-dose dexamethasone significantly ameliorates this lung damage.

This article has been cited by other articles:

				F. Petak, W. Habre, Y. R. Donati, Z. Hantos, and C. Barazzone-Argiroffo Hyperoxia-induced changes in mouse lung mechanics: forced oscillations vs. barometric plethysmography J Appl Physiol, June 1, 2001; 90(6): 2221 - 2230. [Abstract] [Full Text] [PDF]

				A. Lazrak, A. Samanta, K. Venetsanou, P. Barbry, and S. Matalon Modification of biophysical properties of lung epithelial Na+ channels by dexamethasone Am J Physiol Cell Physiol, September 1, 2000; 279(3): C762 - C770. [Abstract] [Full Text] [PDF]

				D. Davidson, E. S. Barefield, J. Kattwinkel, G. Dudell, M. Damask, R. Straube, J. Rhines, C.-T. Chang, and the I-NO/PPHN Study Group Inhaled Nitric Oxide for the Early Treatment of Persistent Pulmonary Hypertension of the Term Newborn: A Randomized, Double-Masked, Placebo-Controlled, Dose-Response, Multicenter Study Pediatrics, March 1, 1998; 101(3): 325 - 334. [Abstract] [Full Text] [PDF]

				N. Barquin, D. E. Ciccolella, K. M. Ridge, and J. I. Sznajder Dexamethasone upregulates the Na-K-ATPase in rat alveolar epithelial cells Am J Physiol Lung Cell Mol Physiol, October 1, 1997; 273(4): L825 - L830. [Abstract] [Full Text] [PDF]